These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
398 related articles for article (PubMed ID: 22290395)
1. Disruption of phospholipid and bile acid homeostasis in mice with nonalcoholic steatohepatitis. Tanaka N; Matsubara T; Krausz KW; Patterson AD; Gonzalez FJ Hepatology; 2012 Jul; 56(1):118-29. PubMed ID: 22290395 [TBL] [Abstract][Full Text] [Related]
2. Soyasaponin A Xiong F; Zheng Z; Xiao L; Su C; Chen J; Gu X; Tang J; Zhao Y; Luo H; Zha L Mol Nutr Food Res; 2021 Jul; 65(14):e2100067. PubMed ID: 34047448 [TBL] [Abstract][Full Text] [Related]
3. Growth arrest and DNA damage-inducible 45α protects against nonalcoholic steatohepatitis induced by methionine- and choline-deficient diet. Tanaka N; Takahashi S; Hu X; Lu Y; Fujimori N; Golla S; Fang ZZ; Aoyama T; Krausz KW; Gonzalez FJ Biochim Biophys Acta Mol Basis Dis; 2017 Dec; 1863(12):3170-3182. PubMed ID: 28844958 [TBL] [Abstract][Full Text] [Related]
4. Ursodeoxycholyl lysophosphatidylethanolamide improves steatosis and inflammation in murine models of nonalcoholic fatty liver disease. Pathil A; Mueller J; Warth A; Chamulitrat W; Stremmel W Hepatology; 2012 May; 55(5):1369-78. PubMed ID: 22183915 [TBL] [Abstract][Full Text] [Related]
5. iPla2β deficiency in mice fed with MCD diet does not correct the defect of phospholipid remodeling but attenuates hepatocellular injury via an inhibition of lipid uptake genes. Zhu X; Gan-Schreier H; Otto AC; Cheng Y; Staffer S; Tuma-Kellner S; Ganzha A; Liebisch G; Chamulitrat W Biochim Biophys Acta Mol Cell Biol Lipids; 2019 May; 1864(5):677-687. PubMed ID: 30735854 [TBL] [Abstract][Full Text] [Related]
6. A metabolomic analysis of omega-3 fatty acid-mediated attenuation of western diet-induced nonalcoholic steatohepatitis in LDLR-/- mice. Depner CM; Traber MG; Bobe G; Kensicki E; Bohren KM; Milne G; Jump DB PLoS One; 2013; 8(12):e83756. PubMed ID: 24358308 [TBL] [Abstract][Full Text] [Related]
7. Hepatic AdipoR2 signaling plays a protective role against progression of nonalcoholic steatohepatitis in mice. Tomita K; Oike Y; Teratani T; Taguchi T; Noguchi M; Suzuki T; Mizutani A; Yokoyama H; Irie R; Sumimoto H; Takayanagi A; Miyashita K; Akao M; Tabata M; Tamiya G; Ohkura T; Hibi T Hepatology; 2008 Aug; 48(2):458-73. PubMed ID: 18666257 [TBL] [Abstract][Full Text] [Related]
8. Bile acids override steatosis in farnesoid X receptor deficient mice in a model of non-alcoholic steatohepatitis. Wu W; Liu X; Peng X; Xue R; Ji L; Shen X; Chen S; Gu J; Zhang S Biochem Biophys Res Commun; 2014 May; 448(1):50-5. PubMed ID: 24747563 [TBL] [Abstract][Full Text] [Related]
9. Lipid zonation and phospholipid remodeling in nonalcoholic fatty liver disease. Hall Z; Bond NJ; Ashmore T; Sanders F; Ament Z; Wang X; Murray AJ; Bellafante E; Virtue S; Vidal-Puig A; Allison M; Davies SE; Koulman A; Vacca M; Griffin JL Hepatology; 2017 Apr; 65(4):1165-1180. PubMed ID: 27863448 [TBL] [Abstract][Full Text] [Related]
10. Fatty acid and endotoxin activate inflammasomes in mouse hepatocytes that release danger signals to stimulate immune cells. Csak T; Ganz M; Pespisa J; Kodys K; Dolganiuc A; Szabo G Hepatology; 2011 Jul; 54(1):133-44. PubMed ID: 21488066 [TBL] [Abstract][Full Text] [Related]
11. VSL#3 probiotic treatment attenuates fibrosis without changes in steatohepatitis in a diet-induced nonalcoholic steatohepatitis model in mice. Velayudham A; Dolganiuc A; Ellis M; Petrasek J; Kodys K; Mandrekar P; Szabo G Hepatology; 2009 Mar; 49(3):989-97. PubMed ID: 19115316 [TBL] [Abstract][Full Text] [Related]
12. Upregulation of osteopontin expression is involved in the development of nonalcoholic steatohepatitis in a dietary murine model. Sahai A; Malladi P; Melin-Aldana H; Green RM; Whitington PF Am J Physiol Gastrointest Liver Physiol; 2004 Jul; 287(1):G264-73. PubMed ID: 15044174 [TBL] [Abstract][Full Text] [Related]
13. Role of fibroblast growth factor 21 in the early stage of NASH induced by methionine- and choline-deficient diet. Tanaka N; Takahashi S; Zhang Y; Krausz KW; Smith PB; Patterson AD; Gonzalez FJ Biochim Biophys Acta; 2015 Jul; 1852(7):1242-52. PubMed ID: 25736301 [TBL] [Abstract][Full Text] [Related]
14. The transition from fatty liver to NASH associates with SAMe depletion in db/db mice fed a methionine choline-deficient diet. Wortham M; He L; Gyamfi M; Copple BL; Wan YJ Dig Dis Sci; 2008 Oct; 53(10):2761-74. PubMed ID: 18299981 [TBL] [Abstract][Full Text] [Related]
15. Glycyrrhizin Alleviates Nonalcoholic Steatohepatitis via Modulating Bile Acids and Meta-Inflammation. Yan T; Wang H; Cao L; Wang Q; Takahashi S; Yagai T; Li G; Krausz KW; Wang G; Gonzalez FJ; Hao H Drug Metab Dispos; 2018 Sep; 46(9):1310-1319. PubMed ID: 29959134 [TBL] [Abstract][Full Text] [Related]
16. TGF-β-SMAD3 signaling mediates hepatic bile acid and phospholipid metabolism following lithocholic acid-induced liver injury. Matsubara T; Tanaka N; Sato M; Kang DW; Krausz KW; Flanders KC; Ikeda K; Luecke H; Wakefield LM; Gonzalez FJ J Lipid Res; 2012 Dec; 53(12):2698-707. PubMed ID: 23034213 [TBL] [Abstract][Full Text] [Related]
17. Pigment Epithelium-Derived Factor (PEDF) Prevents Hepatic Fat Storage, Inflammation, and Fibrosis in Dietary Steatohepatitis of Mice. Yoshida T; Akiba J; Matsui T; Nakamura K; Hisamoto T; Abe M; Ikezono Y; Wada F; Iwamoto H; Nakamura T; Koga H; Yamagishi SI; Torimura T Dig Dis Sci; 2017 Jun; 62(6):1527-1536. PubMed ID: 28365916 [TBL] [Abstract][Full Text] [Related]
18. Role of adipose tissue in methionine-choline-deficient model of non-alcoholic steatohepatitis (NASH). Jha P; Knopf A; Koefeler H; Mueller M; Lackner C; Hoefler G; Claudel T; Trauner M Biochim Biophys Acta; 2014 Jul; 1842(7):959-70. PubMed ID: 24594481 [TBL] [Abstract][Full Text] [Related]
19. Kuppfer cells trigger nonalcoholic steatohepatitis development in diet-induced mouse model through tumor necrosis factor-α production. Tosello-Trampont AC; Landes SG; Nguyen V; Novobrantseva TI; Hahn YS J Biol Chem; 2012 Nov; 287(48):40161-72. PubMed ID: 23066023 [TBL] [Abstract][Full Text] [Related]
20. Protective role of endogenous plasmalogens against hepatic steatosis and steatohepatitis in mice. Jang JE; Park HS; Yoo HJ; Baek IJ; Yoon JE; Ko MS; Kim AR; Kim HS; Park HS; Lee SE; Kim SW; Kim SJ; Leem J; Kang YM; Jung MK; Pack CG; Kim CJ; Sung CO; Lee IK; Park JY; Fernández-Checa JC; Koh EH; Lee KU Hepatology; 2017 Aug; 66(2):416-431. PubMed ID: 28073164 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]